Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system signaling pathways refer to the diverse and complex molecular systems through which neurons, glial cells, and immune cells communicate and regulate CNS function. These pathways include those involved in neurotransmission, immune modulation, inflammatory response, cell survival and death, and are critical for maintaining CNS homeostasis and responding to injury or disease. Targeted modulation of specific CNS signaling pathways is a promising strategy for the treatment of a wide range of neurological disorders, including neurodegenerative diseases, cancer, stroke, and cognitive dysfunction. However, due to their complexity and interconnectedness, precisely targeting these pathways without affecting essential CNS functions or causing adverse effects remains a major therapeutic challenge.
Mechanisms depend on which specific pathway or molecular target is affected, e.g., inhibition of kinases, modulation of immune or neurotransmitter signaling, blockade of neuroinflammatory mediators, etc.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system signaling pathways.